Distribution of gemcitabine pathway genotypes in ethnic Asians and their association with outcome in non-small cell lung cancer patients
- 31 January 2009
- journal article
- Published by Elsevier in Lung Cancer
- Vol. 63 (1), 121-127
- https://doi.org/10.1016/j.lungcan.2008.04.010
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Interethnic variability of warfarin maintenance requirement is explained by VKORC1 genotype in an Asian populationClinical Pharmacology & Therapeutics, 2006
- Advances and Challenges in Fluoropyrimidine Pharmacogenomics and PharmacogeneticsPharmacogenomics, 2005
- Genetic factors influencing Pyrimidine-antagonist chemotherapyThe Pharmacogenomics Journal, 2005
- Role of gemcitabine in cancer therapyFuture Oncology, 2005
- Identification and analysis of single-nucleotide polymorphisms in the gemcitabine pharmacologic pathwayThe Pharmacogenomics Journal, 2004
- (Section A: Molecular, Structural, and Cellular Biology of Drug Transporters) Mammalian Nucleoside TransportersCurrent Drug Metabolism, 2004
- Cancer pharmacogenetics: polymorphisms, pathways and beyondNature Reviews Cancer, 2003
- Pharmacogenomics — Drug Disposition, Drug Targets, and Side EffectsNew England Journal of Medicine, 2003
- Gemcitabine Transport in Xenopus Oocytes Expressing Recombinant Plasma Membrane Mammalian Nucleoside TransportersJNCI Journal of the National Cancer Institute, 1999
- Preclinical characteristics of gemcitabineAnti-Cancer Drugs, 1995